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Previous studies indicated that the acquisition of egg fertilizability during transit through the pars recta portion of the
oviduct in Bufo japonicus is accompanied by hydrolytic conversion of the vitelline coat 40- to 52-kDa components to
39-kDa components induced by a 66-kDa serine protease, “oviductin.” In this study, we cloned a 3028-bp cDNA that
contained an open reading frame encoding 974 amino acids with a calculated molecular mass of 107.6 kDa, including two
protease domains and three repeats of CUB domains. Sequence analysis indicated that the catalytically active 66-kDa
protein comprised an N-terminally located oviductin protease and two CUB domains. The oviductin gene was transcribed
as a part of 6-kb mRNA that was expressed specifically in the cells lining the bottom of epithelial folds in the oviductal pars
recta, and this expression was highly accelerated when the pars recta fragments were cultured in the presence of hCG.
Western blot analyses using antibodies against a protease domain revealed that the catalytically inactive 102-kDa proteins
in the pars recta granules yield 66-kDa catalytically active and 82- and 59-kDa inactive molecules. We propose that the
oviductin translated as 107.6-kDa precursors are processed both N- and C-terminally to give rise to a 66-kDa active form
comprising a serine protease and two CUB domains. © 2002 Elsevier Science (USA)
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Bufo japonicus.INTRODUCTION
An intriguing situation in fertilization of anuran amphib-
ians is that the ovulated coelomic eggs are not fertilizable
1 To whom correspondence should be addressed. Fax: 81-096-
342-3447. E-mail: takamune@gpo.kumamoto-u.ac.jp.
176but become fertilizable after passage through the oviduct.
Studies have elucidated that, in addition to the supply of
jelly envelopes by a long, major “pars convoluta” portion,
the anteriormost “pars recta (PR)” portion contributes to
fertilizability by altering the glycoprotein egg coat [vitelline
coat (VC) or envelope] from a sperm-impenetrable to pen-
etrable state during the sojourn of eggs in this extremely
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short portion (reviews by Katagiri, 1987; Hedrick and Nishi-
hara, 1991). Thus, among the many aspects of the PR-
induced egg-coat alterations that have been most exten-
sively studied by using Bufo japonicus and Xenopus laevis
as models (review, Hedrick and Nishihara, 1991) are ultra-
structural modifications, changes in physical properties,
hydrolytic conversion of glycoprotein components from 40
to 52 kDa to 39 kDa (Bufo) and from 43 kDa to 41 kDa
(Xenopus), an increase in sensitivity to sperm lysin (Bufo),
and an increase in the rate of sperm binding. These alter-
ations accompanying acquisition of egg fertilizability were
perfectly mimicked in vitro by incubating coelomic eggs in
extracts of PR tissue (Katagiri et al., 1982, 1999) or in a
medium containing the contents of secretory granules
(PRGs) from the PR tissue (Takamune et al., 1986). Direct
comparative studies using Bufo and Xenopus revealed that
the envelope macromolecular conversions typical to each
species can be induced in an exactly species-specific way
when coelomic eggs are incubated reciprocally in the PRGs
from heterologous species (Takamune et a1., 1987). A
66-kDa trypsin-like protease termed “oviductin” (Hardy
and Hedrick, 1992) has been identified from PRGs of Bufo
(Takamune and Katagiri, 1987) and Xenopus (Hardy and
Hedrick, 1992). It remains to be determined, however,
whether this hydrolytic degradation of the VC is sufficient
to render the eggs fertilizable (Takamune et al., 1987;
Lindsay et al., 1999; Katagiri et al., 1999). In more recent
studies using Xenopus, the cDNAs for egg envelope glyco-
proteins involved in this oviductin-induced alteration have
been cloned (Kubo et al., 1997; Yang and Hedrick, 1997) and
a plausible mechanism of the gp43-to-gp41 conversion has
been proposed (Kubo et al., 1999). In addition, oviductin
cDNA encoding a unique composite comprising a protease
associated with the CUB domains has been cloned (Lindsay
et al., 1999).
However, no information based on molecular cloning has
been available regarding the oviductal PR-induced acquisi-
tion of egg fertilizability in Bufo. In view of the observa-
tions in Bufo suggesting other contributions of the PR, e.g.,
in induction of the acrosome reaction (Katagiri et al., 1982;
Yoshizaki and Katagiri, 1982), a precise delineation based
on molecular cloning obviously merits investigation in
order to elucidate the molecular mechanisms of oviductal
PR functions. Thus, as an extension of our previous works
on PR-induced acquisition of egg fertilizability in B. japoni-
cus, we cloned cDNA for a 66-kDa protease (oviductin)
from PR granules. We found that this protease is transcribed
in a hormonally dependent manner as a large mRNA
encoding a mosaic protein, as in Xenopus, and is exten-
sively processed posttranslationally.
MATERIALS AND METHODS
Procurement of Eggs and Oviductal Tissues
Sexually mature female toads, Bufo japonicus, were collected
during the hibernation period and were stored at 4°C until use. The
PR, the uppermost 1/20 portion of the oviduct, was removed from
each female either before or 12–13 h after injection of 800 IU
human chorionic gonadotropin (hCG; Teikoku Zoki Co., Tokyo).
The removed PRs, each about 3 cm long, were subjected to
extraction of RNA or were placed in 5 ml of De Boer’s solution (110
mM NaCl, 1.3 mM KCl, 1.3 mM CaCl2, 5 mM Tris–HCl, pH 7.4)
containing 200 IU hCG for culture at 20°C for 0–4 h. Coelomic and
uterine eggs were obtained 12–13 h and 18–20 h after hormonal
stimulation of females, respectively. Uterine eggs were dejellied by
NaCN as described previously (Takamune and Katagiri, 1987). VCs
isolated from coelomic and uterine eggs were used as a substrate for
oviductal protease samples or for electrophoretic analyses by
sodium dodecyl sulfate–polyacrylamide electrophoresis (SDS–
PAGE).
Pars Recta Granules (PRGs)
Secretory granules in the hormonally stimulated PR tissues
(PRG) were isolated by Percoll density gradient centrifugation as
described previously (Takamune and Katagiri, 1987) and suspended
in Ca2-rich De Boer’s solution (110 mM NaCl, 1.3 mM KCl, 10
mM CaCl2, 10 mM Tris–HCl, pH 8.0). This was followed by
freezing (80°C) and thawing to allow the contents of the PRGs to
be released.
Amino Acid Sequencing
The contents of the PRGs were subjected to SDS–PAGE accord-
ing to the method of Laemmli (1970). After a run on 10% gel,
samples were electroblotted onto a polyvinylidene difluoride
(PVDF) membrane (Immobilon P; Millipore, Tokyo) and stained
with Coomassie brilliant blue R-250. The band corresponding to a
66-kDa protein was sliced out and processed to determine the
amino acid sequence by the pulsed-liquid Edman degradation
method using a protein sequencer (Model 475A; Applied Biosys-
tems Inc.).
Isolation of Bufo Oviductin cDNA
The PR tissues were removed from females 12–13 h after
injection of hCG, and total RNA was extracted by the acid
guanidinium thiocyanate-phenol-chloroform method (Chomczyn-
ski and Sacchi, 1987). Total RNA (3 g) was reverse-transcribed
by using SuperScript II (Gibco BRL) and a random primer
(TaKaRa Biochemicals, Japan). For amplification of the DNA
fragment corresponding to the N-terminal region of oviductin,
sense and antisense degenerative primers were designed:
5-GGIGGIACIWSIGCIGTIAARGG-3 (sense) on the basis of
the oviductin N-terminal amino acid sequence (GGTSAVKG),
which was determined by Edman sequencing of the isolated Bufo
oviductin; and 5-RGGKCCICCRGARTCWCC-3 (antisense) on
the basis of the conserved amino acid sequence flanking the Ser
of serine active site protease (GDSGGP). PCR was performed by
using Taq DNA polymerase (TaKaRa Taq; TaKaRa Biochemi-
cals) with an initial denaturation at 95°C for 5 min, followed by
40 cycles of denaturation at 95°C for 1 min, annealing at 42°C
for 1 min, and extending at 72°C for 1 min. The RT-PCR product
(570 bp) was inserted into a pGEM-T Easy Vector (Promega).
To obtain cDNA that contained the entire open reading frame, a
PR cDNA library was constructed. The poly(A)-rich RNA was
isolated from total RNA by using an Oligotex-dT30 Super
(TaKaRa Biochemicals). Double-stranded cDNA was synthesized
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from poly(A)-rich RNA by using a TimeSaver cDNA Synthesis Kit
(Amersham Pharmacia Biotech), and this was followed by ligation
with an EcoRI–NotI adapter (Amersham Pharmacia Biotech) and
insertion into the EcoRI site of  Zap II vector (Stratagene). The
construct was packaged by using the cell extracts (GigaPack III
Gold; Stratagene). Screening of the cDNA was carried out by
hybridization of approximately 2 105 independent clones with an
RT-PCR product that was labeled with digoxigenin (DIG) using a
DIG DNA Labeling and Detection Kit (Roche, Germany). A posi-
tive plaque was selected, and cDNA in pBluescript SK() was
obtained by in vivo excision using ExAssist helper phage (Strat-
agene).
Since the cDNA obtained by conventional hybridization lacked
an initiation codon, 5 rapid amplification of cDNA ends (5RACE)
was performed by using a 5RACE System for Rapid Amplification
of DNA Ends (version 2.0; Gibco BRL). The amplified cDNA was
digested with PstI and SpeI and inserted into the PstI/SpeI site of
pBluescript II SK(). Three independent clones were selected, and
their sequences were determined.
DNA Sequencing
The cDNA was digested both with HindIII and EcoRI, and the
resulting two fragments (approximately 950 bp and 1850 bp) were
subcloned into the HindIII/EcoRI site of pBluescript II SK(). A
nested series of deletions was created for the large fragment by
using an Exo-Mung Deletion Kit (Stratagene), and the resulting
clones as well as the small fragment and cDNAs amplified by
RT-PCR and 5RACE were sequenced by the dideoxy chain termi-
nation method of Sanger et al. (1977) using a Thermo Sequence
Cycle Sequencing Kit (Amersham Pharmacia Biotech) and a DNA
Sequencer (LiCor 4200 Automated DNA Sequencing Systems;
Aloka, LTD.).
In Situ Hybridization
RNA probes for in situ hybridization were made by the method
of Hirota et al. (1992). Briefly, linearized oviductin cDNA (2797 bp)
was used as a template for synthesizing the RNA probe by using
DIG RNA Labeling Mix (Roche, Germany) as a substrate. The
labeled RNA probe was dissolved in hybridization buffer to a final
concentration of 1.0 g/ml and heated at 85°C for 10 min just
before use for hybridization.
Oviductal PR tissues were fixed with 4% paraformaldehyde in
PBS (70 mM NaCl, 56.7 mM Na2HPO413H2O, 13.3 mM
NaH2PO42H2O, pH 7.4) for 4 h on ice, dehydrated through an
ethanol series, and embedded in paraffin. Sections (7 m thick)
spread on silanized slides (Dako, Japan) were deparaffinized and
treated successively with Proteinase K (Roche, Germany), parafor-
maldehyde, acid, and triethanolamine-HCl/acetic anhydride, ac-
cording to the method of Hirota et al. (1992). After hybridization
with the sense or antisense probe at 50°C for 16 h, the sections
were treated with RNase A to remove excess probe. Specifically
hybridized DIG-labeled probes were visualized with alkaline
phosphatase-conjugated anti-DIG antibody (Roche, Germany) and
NBT/BCIP solution (Roche, Germany) according to the manufac-
turer’s instructions.
For in situ hybridization of whole tissue blocks, oviducts were
fixed with 4% paraformaldehyde in PBS for 4 h on ice, washed in
PBST (0.1% Tween 20 in PBS), and decolorized in 5% H2O2/83%
methanol for 6 h. After brief digestion with Proteinase K, the
tissues were postfixed with 0.1% glutaraldehyde/4% paraformal-
dehyde, and then aldehyde residues were blocked with 0.1%
NaBH4. After hybridization with the sense or antisense RNA probe
at 63°C for 16 h and thorough washing, the tissues were treated
with RNase A to remove excess probes. Specifically bound probes
were detected by incubating the tissues in alkaline phosphatase-
conjugated anti-DIG antibody followed by treatment with NBT/
BCIP solution. The tissues were dehydrated through a methanol
series and cleared by glycerol.
Northern Hybridization
Total RNA (20 g) was electrophoresed on 1% agarose gel
containing 3.7% formaldehyde and blotted onto a nylon membrane
(Hybond N; Amersham Pharmacia Biotech). This was followed by
hybridization with oviductin cDNA labeled with DIG using a DIG
DNA Labeling and Detection Kit. The membrane was washed
successively in 0.1% SDS/2 SSPE (0.3 M NaCl, 2 mM EDTA, 20
mM NaH2PO42H2O, pH 7.4) and in 0.1% SDS/0.1 SSPE, and was
treated with alkaline phosphatase-conjugated anti-DIG antibody
and then with treatment with NBT/BCIP solution for detection of
DIG.
Semiquantification of Oviductin mRNA
Total RNA (3 g) extracted from the oviductal PR or pars
convoluta that had been incubated in 5 ml of De Boer’s solution
containing 200 IU hCG at 20°C for 0–6 h was reverse-transcribed
in 20 l of the reaction mixture (75 mM KCl, 3 mM MgCl2, 10 mM
DTT, 1 mM dNTP, 100 pmol of a random primer, 200 U Super-
Script II, 50 mM Tris–HCl, pH 8.3) at 42°C for 50 min. Following
dilution of the reaction mixture with 60 l distilled water, 1 l of
the diluted mixture was used as a template for a 50-l PCR reaction
containing 100 pmol of specific primers for oviductin and EF-1.
Primer sequences were based on the sequences of oviductin (DNA
Data Bank of Japan, Accession No. AB070367) and EF-1 (DNA
Data Bank of Japan, Accession No. AB066590). Sense primers for
oviductin and EF-1 were 5-AGATGGGAAGCACTTCTGTG-3
and 5-TATTGGTACAGTACCCGTCG-3, corresponding to nu-
cleotides 291–310 and 189–208, respectively. Antisense primers for
oviductin and EF-1 were 5-CCTTCTGGAAATCCTGCACA-3
and 5-GGATAATAACCTGGGCAGTG-3, corresponding to nu-
cleotides 751–770 and 435–454, respectively. PCR was performed
with an initial denaturation at 95°C for 5 min, followed by 15
cycles of denaturation at 95°C for 1 min, annealing at 50°C for 1
min, and extending at 72°C for 1 min. PCR products (10 l) were
electrophoresed on a 2% agarose gel and blotted onto a Hybond
N. After Southern hybridization with either DIG-labeled oviduc-
tin cDNA or EF-1 cDNA and visualization of DIG according to
the methods described above, the intensity of the hybridization
signals was determined by using image analyzer software (LaneSpot
Analyzer Software; ATTO LTD.). The relative amounts of oviduc-
tin mRNA in the PR at various incubation times were normalized
to EF-1.
Production of Antibody and Western Blotting
A prokaryotic expression vector for the protease  domain in
oviductin fused at the C terminus with hexahistidine was
constructed as follows. A DNA fragment encoding a part of the
protease  domain of oviductin was amplified by PCR with a
sense primer containing BamHI site, 5-CCGGATCCGGAGA-
TCACGATTTCGCTG-3, and an antisense primer containing
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EcoRI site, 5-CCGAATTCAGCCAGTTGAGAAGCCTC-3.
The positions of these sequences in the cDNA were nucleotides
400 –418 and 948 –965, respectively. The PCR conditions were as
follows: an initial denaturation at 95°C for 5 min, followed by 40
cycles of denaturation at 94°C for 30 s, annealing at 50°C for
30 s, and extending at 72°C for 1 min. The PCR product was
digested both with BamHI and EcoRI and inserted into the
BamHI/EcoRI site of pET21a (Promega).
The protease  domain-hexahistidine fusion protein was ex-
pressed in Escherichia coli BL21 and purified by using Chelating
Sepharose Fast Flow (Amersham Pharmacia Biotech) according to
the manufacturer’s instructions. An antigen solution made by
emulsifying 100 g of purified fusion proteins in 50 l of GERBU
adjuvant 100 (GERBU Biotechnik GmbH) was injected subcutane-
ously into a mouse (BALB/c). The animal received five subcutane-
ous injections of the antigen solution at 10-day intervals. The
antiserum obtained will henceforth be referred to as anti- domain
antiserum.
The PRG contents separated by SDS–PAGE using 7.5% gel were
electroblotted onto Immobilon P. The transblotted membranes
were treated with anti- domain antiserum (1:200 dilution) and
then with alkaline phosphatase-conjugated goat anti-mouse IgG 
A  M (1:500 dilution; ZYMED Laboratories). After washing, the
membranes were treated with NBT/BCIP solution for visualization
of immunological reactions.
RESULTS
Nucleotide Sequence of Oviductin cDNA and
Predicted Amino Acid Sequence
The contents of the PRG were electrophoresed on SDS–
PAGE and electroblotted onto a PVDF membrane. The band
corresponding to a 66-kDa protein was excised, and its
N-terminal amino acid sequence was determined to be
IVGGTSAVKGESP. A sense primer was designed on the
basis of the amino acid sequence GGTSAVKG, and an
antisense primer was constructed on the basis of the amino
acid sequence GDSGGP, which is conserved in various
serine proteases. RT-PCR employing both of these primers
and oviductal PR mRNA as templates gave rise to a short
cDNA (570 bp). By screening a PR cDNA library using this
short cDNA as a probe, a 2797-bp-long cDNA was selected.
The nucleotide sequence of this cDNA lacked both a
poly(A) signal sequence and a poly(A) tail. The predicted
amino acid sequence revealed, however, that this cDNA
has exactly one open reading frame that contains the
sequences corresponding to the N-terminal amino acid
sequence of oviductin determined by Edman sequencing,
the sequence conserved among serine proteases, and a TAA
stop codon at nucleotide 3007. Although a start codon was
not present in this cDNA, the base sequence of a 132-bp
3-terminal region of a 5RACE product was identical with
that of the 5-terminal region of our cDNA, indicating that
the 5RACE products represented the 5 upstream portion
of oviductin cDNA. In the 3028-bp-long oviductin cDNA,
of which nucleotide sequence data appears in the DDBJ
nucleotide sequence database with the Accession No.
AB070367, none of the ATG codons present after an ATT
stop codon at nucleotide 4, i.e., those at nucleotides 85, 112,
115, and 127, exhibited Kozak’s nearby sequence CCRC-
CATG typically found around the start codon (Kozak,
1984). Thus, we predicted that the ATG at nucleotide 85
actually represents the initiation site of translation. Assum-
ing this ATG sequence is a start site, the predicted trans-
lated protein comprises 974 amino acid residues with a
calculated molecular mass of 107.6 kDa. This molecular
weight value is much higher than the value of 66 kDa
estimated previously based on SDS–PAGE analysis of puri-
fied oviductin (Takamune and Katagiri, 1987), suggesting an
extensive posttranslational processing for activation of pro-
teolytic activity.
Specific Expression of Oviductin mRNA
in Oviductal PR
Northern blot analyses showed that our cDNA hybrid-
ized with the PR mRNA at approximately 6 kb in size (Fig.
1), indicating the presence of a fairly long untranslated
portion either at 5, 3, or both regions that were not
sequenced. No hybridization with the oviductin cDNA was
observed at all when total RNAs from the oviductal pars
convoluta and liver were tested (not shown).
The tissue-specific expression of our cDNA was further
confirmed by in situ hybridization studies. Whole-mount in
situ hybridization of an oviductal fragment (Fig. 2A) showed
that the oviductin mRNA is expressed in the PR but not in
the pars convoluta portions. In situ hybridization on the PR
tissue sections revealed the expression of oviductin mRNA
preferentially in those cells localized in the bottom of
epithelial folds (Figs. 2B and 2C), a localization consistent
with that of the epithelial Type I cells known to possess
PRGs (cf., Katagiri et al., 1982).
FIG. 1. Northern blot of total RNA extracted from PR tissue
showing the Bufo oviductin message (arrow). Numerals indicate
RNA sizes (base) of authentic RNAs (left) and oviductin mRNA
(right), respectively. Twenty micrograms of total RNA was loaded.
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The expression of oviductin mRNA was induced or
accelerated by hormonal stimulation of the oviductal PR
tissue in culture. As depicted in Fig. 3, the level of oviductin
mRNA was extremely low, although not null, in tissues
from hibernating toads, but increased sharply to a plateau
level within 2 h in response to exposure to hCG in organ
culture.
Sequence Analysis
Comparison of the deduced amino acid sequence of the
Bufo oviductin with that of the Xenopus oviductin, which
was recently reported by Lindsay et al. (1999), revealed that
they had an overall 46% identity to each other (Fig. 4). The
Bufo and Xenopus oviductins had the same general struc-
tural frameworks, comprising an arrangement of two pro-
tease domains that were interrupted by two repeats of CUB
domains, followed by the third CUB domain in the more
C-terminal side (Fig. 4). Alignment of two protease do-
mains, designated oviductin- and - by Lindsay et al.
(1999), with those of the Xenopus counterparts and other
established proteases, e.g., bovine trypsinogen and human
chymotrypsinogen, showed that the Bufo  and  domains
shared with other proteases the presence of three predicted
catalytically active sites containing His, Asp, and Ser (Fig.
5, dots). However, in the Bufo  domain, the active site His
was replaced by Asp, whereas it was replaced by Ser in the
Xenopus  domain. Thus, similar to situations in the
Xenopus counterpart (Lindsay et al., 1999), the oviductin 
domain in Bufo is not likely to be proteolytically active.
N-terminal amino acid residue confirmed by Edman-
sequencing of purified Bufo oviductin was present in the 
domain, and its position was identical to that in other
mature proteases produced by processing for proteolytic
activation (Fig. 5, arrow; Rawlings and Barrett, 1994). In
addition, both Bufo and Xenopus  domains shared with
trypsinogen but not with chymotrypsinogen the presence of
amino acid residues that were predicted to be involved in
binding with Ca ions (Glu; Fig. 5, asterisk) and substrate
specificity (Asp; Fig. 5, arrowhead). This is consistent with
previous results showing that both Bufo and Xenopus
oviductins are trypsin-like serine proteases (Takamune and
Katagiri, 1987; Hardy and Hedrick, 1992) requiring Ca2 for
stabilization (Takamune and Katagiri, 1987), like bovine
trypsin (Delaage and Lazdunski, 1967). These results clearly
FIG. 2. Expression profiles of oviductin mRNA in the oviductal
tissues. (A) Whole-mount in situ hybridization of an oviductal
fragment showing the expression in the PR but not in the pars
convoluta (PC). (B) In situ hybridization of a cross section through
the PR showing the expression of the message in the cells localized
in the bottom of epithelial folds. (C) A section next to (B) stained
with hematoxylin and eosin. L, oviductal lumen. Bars represent 5
mm (A) and 100 m (B, C), respectively.
FIG. 3. Induction of oviductin mRNA expression by incubation of
oviductal PR tissues with hCG. (A) Southern blot showing levels of
oviductin mRNA in PR or pars convoluta (PC) tissues after treat-
ment with 40 IU/ml hCG for various periods as indicated. The
oviductin cDNA fragments amplified by RT-PCR were Southern-
blotted with labeled oviductin or EF-1 cDNA as a probe. (B)
Relative amounts of oviductin mRNA in the PR tissues treated
with hCG for various periods, normalized to EF-1. Vertical bars
indicate the means  standard errors of five replicates.
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indicate that the  domain constitutes the functional por-
tion for the proteolytic activity of oviductin.
Apart from the protease domains, the deduced amino acid
sequence of oviductin contained three CUB domains, each
spanning approximately 110 amino acid residues. Of these
CUB domains, two repeats located between  and  do-
mains (CUB1 and CUB2, Fig. 4) possessed four conserved
Cys residues known to be important for disulfide bond
formation, but the other (CUB3) domain possessed only two
Cys residues.
Posttranslational Activation of Oviductin Function
The fairly large size of the molecule suggested from the
deduced amino acid sequence based on the oviductin cDNA
data prompted us to test the possibility that oviductin
becomes proteolytically active, probably due to activation
of the  domain, after posttranslational processing. Based
on Western blot analysis using antibodies against the ovi-
ductin  domain, the molecular mass of the major antibody-
reactive constituent in freshly prepared PRGs, exhibiting
no VC-hydrolyzing activity (Fig. 6B, lane 3), was estimated
to be approximately 102 kDa, a value close to predicted
molecular mass of 107.6 kDa (Fig. 6A, lane 1). When PRGs
that had been frozen and thawed so that their VC-
hydrolyzing activity would be released (Fig. 6B, lane 4) were
Western-blotted, the 102-kDa molecule disappeared, but
66-kDa molecules in association with 82- and 59-kDa
molecules were present in this active preparation (Fig. 6A,
lane 2). These results indicate that the cDNA cloned in this
study encodes oviductin whose translational products
stored in the PR granules need to be processed to become a
proteolytically active 66-kDa form.
DISCUSSION
The 3028-bp cDNA isolated in this study lacked both a
poly(A) sequence and polyadenylation signal (Fitzgerald and
Shenk, 1981) and was shown to code for approximately half
of the 6-kb mRNA that is actually expressed in the oviduc-
tal PR tissue. However, an open reading frame identified in
this cDNA is sufficient to enable prediction of the basic
structural framework of oviductin and the primary struc-
ture of the protease domain. The following evidence indi-
cates that the cDNA presented here encodes Bufo oviduc-
tin: (1) its sequence contains at upstream portion an
N-terminal 13-amino acid sequence of functional oviduc-
tin, (2) its sequence contains the catalytic residues con-
served among serine proteases (Fig. 5), (3) its sequence
contains amino acid residues that are known to be involved
in Ca2-binding and substrate specificity in bovine trypsin
(Fig. 5), (4) its transcripts are localized exclusively in the
epithelial cells of oviductal PR (Figs. 1 and 2), (5) its
transcription is efficiently enhanced upon incubation of
oviductal PR tissue in hCG (Fig. 3), and (6) the antibodies
directed against the cDNA-encoded proteins react with the
functionally active 66-kDa molecules (Fig. 6). In functional
aspects, the observed hormonally induced enhancement of
its transcription is quite compatible with the well-
documented necessity for pituitary hormone stimulation of
hibernating females to obtain efficient PRGs (Katagiri et al.,
1982; Takamune and Katagiri, 1987).
The overall domain structure of the Bufo oviductin
presented here is essentially the same as that of the Xeno-
pus counterparts that have recently been cloned and se-
quenced by Lindsay et al. (1999), in that it comprises two
protease and three CUB domains arranged in a specific
order. This is not surprising in view of the previous evi-
dence showing that the PRGs from these two anuran
amphibians reciprocally affect heterologous VCs to induce
the conversion of the latter in a manner specific to each
species of the egg coats (Takamune et al., 1987). We found
FIG. 4. Comparison of amino acid sequences of oviductins from
Bufo and Xenopus (based on Lindsay et al., 1999). Identical amino
acid residues are shaded, and gaps (-) are introduced to maximize
homology. The regions of two protease and three CUB domains are
boxed with solid and broken lines, respectively. Cysteine residues
predicted to be involved in the formation of disulfide bonds for
secondary structure in the CUB domain are shaded with black.
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in this study that the 66-kDa functional Bufo protease is
encoded for in cDNA as a part of a predicted 107.6-kDa
protein. Likewise, in Xenopus, the pertinent protease with
a molecular mass of 66 kDa (Hardy and Hedrick, 1992) was
shown to be coded for in cDNA as a predicted 110.6-kDa
protein (Lindsay et al., 1999). These findings indicate that
an extensive posttranslational processing occurs to give rise
to a proteolytically active form.
The oviductin stored in PRGs must lack signal peptides
at the N-terminal side (Blobel and Dobberstein, 1975).
Another processing that results in exposure of the
N-terminal amino acid sequence of mature protease may
occur due to proteolytic cleavage after Arg49, in exactly the
same way as that proposed for Xenopus oviductin after
Arg45 (Lindsay et al., 1999). In analogy with activation of
human chymotrypsin (Tomita et al., 1989), tryptic pro-
teases, possibly including oviductin itself, would be in-
volved in this processing. Thus, mature 66-kDa molecules
exhibiting VC-hydrolyzing activity would contain the pro-
tease  domain at the N terminus in association with two
C-terminally aligned CUB domains. This assumption is
supported by the fact that the  domain, but not the 
domain, contains amino acid residues that, in bovine tryp-
sin, are known to be involved in substrate specificity and in
Ca2 binding for increasing its stability by retarding auto-
lytic degradation (Fig. 5; Delaage and Lazdunnski, 1967;
Bode and Schwager, 1975). Consistent with this, Bufo
oviductin does hydrolyze the peptidyl-Arg-MCA in a Ca2-
dependent way (Takamune and Katagiri, 1987).
The calculated molecular mass of 55.5 kDa including
protease  domain (253 amino acids) and two CUB domains
(227 amino acids) is smaller than the actually determined
FIG. 5. Multiple alignment of the Bufo and Xenopus oviductin protease domains ( and ) with bovine trypsinogen (Le Huerou et al., 1990)
and human chymotrypsinogen (Tomita et al., 1989). Open circles indicate the amino acid residues common to Bufo and Xenopus 
domains, trypsinogen, and chymotrypsinogen. The cleavage site for protease activation is marked with an arrow. Amino acid residues at
the active site are marked with dots, and those different from the active site are shaded. The positions of the amino acid residues predicted
to be involved in stabilization of protease by binding with calcium ions are marked with an asterisk, with the potential amino acid residues
shaded with black. The S1 to S3 subsites of serine proteases are boxed. Aspartic acid residues that are thought to form an electrostatic bond
with the P1-arginine (or -lysine) side chain of the substrate are shaded with black at the position marked with an arrowhead.
FIG. 6. Posttranslational processing and activation of Bufo oviduc-
tin. (A) Ten micrograms each of freshly prepared PRG (lane 1) and
frozen and thawed PRG (FT-PRG; lane 2) were Western blotted by
using antibodies against the oviductin  domain. (B) Five micrograms
each of the VC from coelomic eggs (CE) (lane 1), uterine eggs (lane 2),
CE treated with fresh PRG (lane 3), or CE treated with FT-PRG (lane
4) were electrophoresed and stained with Coomassie brilliant blue.
Numerals indicate molecular weights in kDa.
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value of 66 kDa of mature oviductin. At present, there is no
information regarding C-terminal processing, and it is not
known whether protease  domain, presumably proteolyti-
cally inactive due to deficiency of one active site, is in-
cluded in mature active molecules. From a simple molecu-
lar size estimation, the mature 66-kDa oviductin possibly
includes the N-terminal half of the  domain, although a
possible contribution by glycosylation cannot be excluded.
In any case, the occurrence of 82- and 59-kDa inactive
molecules accompanying the appearance of 66-kDa active
molecules (Fig. 6A, lane 2) suggests multistepwise modifi-
cation of PRGs that occurs after translation. Perhaps the
82-kDa molecules represent a proenzyme form, whereas the
59-kDa molecules could be derived from degradation of
66-kDa molecules. The latter possibility may be tenable in
view of the unusually unstable nature of purified oviductin
(Takamune and Katagiri, 1987) and its temporally and
spatially transient functions in affecting the VCs during the
short sojourn of eggs in the oviductal PR.
In analogy with the Xenopus counterpart (Lindsay et al.,
1999), the Bufo oviductin cDNA possesses three repeats of
CUB domains, two of which are located C-terminally to
protease  domain and the third one next to  domain. The
first two repeats in Bufo, probably coupled to a  domain to
form a proteolytically active 66-kDa molecule, possess all
of the four conserved Cys residues characteristic to CUB
domains, while the third one lacks two of them (Fig. 4). The
CUB domains have been found at the C-terminal side of the
protease domain in a variety of proteins functioning in
regulation of developmental processes, such as Tolloid,
MBP-1, Uegf, and A5 (Bork and Beckmann, 1993). Besides
these, the domain has been found also in the hatching
enzymes of Caenorhabditis elegans (Hishida et al., 1996)
and X. laevis (Katagiri et al., 1997) as well as in QuCAM-1,
a potentially embryo coat-affecting protein of the quail
(Elaroussi and de Luca, 1994). Although the exact function
of these protease-associated CUB domains is still a matter
of speculation, the spermadhesins located in the mamma-
lian sperm head, comprising essentially a single CUB do-
main, deserve attention because of their predicted function
in mediating binding of sperm to carbohydrates of a zona
pellucida (Calvete et al., 1994). This function of CUB
domains to aid binding to the VC matches the spatially
limited function of oviductin that may be accomplished by
its firm binding to the target 40- to 52-kDa glycoproteins in
the VC. In an interesting analogy to this, the Xenopus
hatching enzyme possessing a metalloprotease domain and
two repeats of the CUB domain (Katagiri et al., 1997) could
be converted to a state that is protease-active but not active
toward the natural substrate egg coat, accompanied by a
loss of approximately 20-kDa molecules (Fan and Katagiri,
1997). The possibility that this loss is due to deficiency of
CUB domains requires substantiation by studies using a
molecular marker to trace the CUB domains.
Our previous attempts to fertilize coelomic Bufo eggs by
treatment with purified oviductin were not successful de-
spite fully induced hydrolytic conversion of VC, suggesting
that the proteolytic processing by oviductin is not sufficient
to render the eggs fertilizable (Takamune and Katagiri,
1987). The observed dramatic increase in sperm binding to
the Xenopus envelopes after treatment with purified ovi-
ductin together with the success in fertilizing coelomic
eggs by treatment with trypsin (Lindsay and Hedrick, 1998)
led Lindsay et al. (1999) to conclude that oviductin alone is
the oviductal factor responsible for converting the egg
envelope to a sperm-penetrable form. It must be noted,
however, that short-term treatment with PR extract could
not render coelomic Xenopus eggs fully fertilizable despite
complete conversion of envelope 43-kDa glycoprotein to
41-kDa glycoprotein and a dramatic increase in sperm
binding to the envelope to a level equivalent to that
exhibited by the envelope from uterine eggs (Katagiri et al.,
1999). Thus, it is possible that the oviductal PR provides
factors other than oviductin to render the eggs fully fertil-
izable. Perhaps one of the candidates for these PR-derived
factors is the acrosome reaction-inducing substance that
has been proposed for B. japonicus (Katagiri et al., 1982;
Yoshizaki and Katagiri, 1982) and most recently for Xeno-
pus as well (Ueda et al., 2002). Further investigation of the
exact molecular entities of these factors and their tissue
origin is needed in order to elucidate the role of oviductal
PR in mediation of gamete fusion in amphibians.
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